Cargando…
Varying effects of recommended treatments for heart failure with reduced ejection fraction: meta‐analysis of randomized controlled trials in the ESC and ACCF/AHA guidelines
The aim of this paper is to evaluate the treatment effects of recommended drugs and devices on key clinical outcomes for patients with heart failure with reduced ejection fraction (HFREF). Randomized controlled trials (RCTs) listed in the 2012 HF guideline from the European Society of Cardiology as...
Autores principales: | Thomsen, Marius Mark, Lewinter, Christian, Køber, Lars |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5107974/ https://www.ncbi.nlm.nih.gov/pubmed/27867524 http://dx.doi.org/10.1002/ehf2.12094 |
Ejemplares similares
-
ACC/AHA/HFSA 2022 and ESC 2021 guidelines on heart failure comparison
por: Behnoush, Amir Hossein, et al.
Publicado: (2022) -
Management of Heart Failure with Reduced Ejection Fraction after ESC 2016 Heart Failure Guidelines: The Linx Registry
por: de Frutos, Fernando, et al.
Publicado: (2020) -
Comparison of ESC and ACC/AHA guidelines for myocardial revascularization
por: Stirrup, Jim, et al.
Publicado: (2017) -
The diagnostic and prognostic utility of risk factors defined by the AHA/ACCF on the evaluation of cardiac disease in liver transplantation candidates
por: Alexander, Sarah, et al.
Publicado: (2019) -
Physical Frailty and Use of Guideline‐Recommended Drugs in Patients With Heart Failure and Reduced Ejection Fraction
por: Kondo, Toru, et al.
Publicado: (2023)